Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG
Long Left Internal Mammary Artery Patch on Left Anterior Descending Coronary Artery in Coronary Artery Bypass Grafting
1 other identifier
observational
50
0 countries
N/A
Brief Summary
To assess the effect of LIMA patch as a method for the reconstruction on diffusely diseased LAD in the early and midterm outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedDecember 15, 2023
December 1, 2023
1 year
December 8, 2023
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
assess the effect of LIMA patch as a method for the reconstruction on diffusely diseased LAD in the early and midterm outcomes
asses postoperative new arrhythmia//use of Inotropes// second session of surgery
first week postoperative
Interventions
During coronary artery bypass surgery, the surgeon removes a piece of blood vessel from the leg, chest, arm, or belly. Then, the surgeon uses that piece of blood vessel (called a "graft") to reroute blood around the blocked artery.
Eligibility Criteria
Perioperative data values were coded, processed and collected in tables. Qualitative data were described using number and percent. Quantitative data were described using median and standard deviation. Statistical significance was assumed if a p value of 0.05 or less was achieved.
You may qualify if:
- Any patient male,( or female) and his(or her) age from 30-90 years have Ischemic Heart Disease for CABG with diffusely diseased LAD.
You may not qualify if:
- Any patient performed open heart surgery before
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Todorov IP, Todorova ZP, Nikolov DP. Angioplasty balloon occlusion of LIMA graft in reoperations of patients with prosthetic valve endocarditis and patent LIMA-LAD graft. Kardiochir Torakochirurgia Pol. 2022 Dec;19(4):199-204. doi: 10.5114/kitp.2022.122089. Epub 2022 Dec 24.
PMID: 36643344BACKGROUNDYang T, Yuan X, Li B, Zhao S, Sun H, Lu M. Long-term outcomes after coronary artery bypass graft with or without surgical ventricular reconstruction in patients with severe left ventricular dysfunction. J Thorac Dis. 2023 Apr 28;15(4):1627-1639. doi: 10.21037/jtd-22-1214. Epub 2023 Mar 23.
PMID: 37197557BACKGROUND
Study Officials
- STUDY CHAIR
Sameh Abdelrahman, professor
Professor of Cardiothoracic surgery
- PRINCIPAL INVESTIGATOR
Ahmed Mohamed Taha, professor
Professor of Cardiothoracic surgery
- STUDY DIRECTOR
Mohammed Hasan Osman, professor
Professor of General surgery Maxillofacial surgery
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
December 8, 2023
First Posted
December 15, 2023
Study Start
January 1, 2024
Primary Completion
January 1, 2025
Study Completion
December 1, 2025
Last Updated
December 15, 2023
Record last verified: 2023-12